Correction: Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer(PLoS ONE (2018) 13:7(e0199012) DOI: 10.1371/journal.pone.0199012)

Knut M. Wittkowski, Christina Dadurian, Martin P. Seybold, Han Sang Kim, Ayuko Hoshino, David Lyden

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

In the “HPaCD is more effective than HPbCD against migration of breast cancer cells” subsection of the Results (page 14 of the PDF file), the first word of the third paragraph is incorrect. The cyclodextrin used in [72–74] was MβCD. In this study, the authors used HP cyclodextrins because of lower cytotoxicity. Thus, the second sentence in this paragraph is incorrect. The correct sentence is: To determine whether inhibition of migration is caused by cyclodextrins depleting cholesterol, as assumed previously, the published activity from wound healing experiments comparing MβCD against control was replicated using HPβCD, and complemented with novel activity results comparing HPαCD against control, both in MDA-MB 231 (ER-) and MCF-7 (ER+) human breast epithelial cell lines.

Original languageEnglish
Article numbere0214826
JournalPloS one
Volume14
Issue number3
DOIs
Publication statusPublished - 2019 Mar

Bibliographical note

Publisher Copyright:
© 2019 Wittkowski et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • General

Fingerprint

Dive into the research topics of 'Correction: Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer(PLoS ONE (2018) 13:7(e0199012) DOI: 10.1371/journal.pone.0199012)'. Together they form a unique fingerprint.

Cite this